TAX 3503, A prospective registry -A Randomized, Open label, Muiticenter, Phase III, 2 Arm Study of Androgen Deprivation with Leuprilode +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects with a Rising PSA Following D. local therapy
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Memorial Sloan-Kettering Cancer Center
Start Date
August 1, 2013
End Date
June 14, 2017
Administered By
Duke Cancer Institute
Awarded By
Memorial Sloan-Kettering Cancer Center
Start Date
August 1, 2013
End Date
June 14, 2017